"Magnetic" beta amyloid 1-42 (Aβ1-42) immunomagnetic reduction detection reagent - Taiwan Registration 998e544eb57fcadc234f4346ce4995d1
Access comprehensive regulatory information for "Magnetic" beta amyloid 1-42 (Aβ1-42) immunomagnetic reduction detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 998e544eb57fcadc234f4346ce4995d1 and manufactured by MAGQU CO., LTD.. The authorized representative in Taiwan is MAGQU CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
The efficacy has been changed to: This product can only be used as one of the reference materials for the clinical diagnosis of Alzheimer's disease, and the results of this test cannot be used as the only basis for confirmation. This product uses immunomagnetic reduction analysis to quantitatively detect the concentration of Aβ1-42 protein in human plasma, or the ratio of its concentration to the "magnetic amount" Tau protein immunomagnetic reduction test dose test concentration (Aβ1-42 x Tau) or "magnetic amount" beta amyloid 1-40 (Aβ1-40) immunomagnetic reduction test dose concentration (Aβ1-42/Aβ1-40) As a test value, it needs to be combined with clinical data and other test results as a reference to help diagnose Alzheimer's disease.
C Immunology and microbiology
C.9999 Miscellaneous
QMS/QSD;; 國產
Dates and Status
Dec 08, 2020
Dec 08, 2025